similar to human dilated cardiomyopathy (DCM), has been developed. The immunisation by
myosin, purified from DCM-affected human heart initiated the following DCM-like myocardial
damage: myocytolysis, cardiosclerosis, thinning of left ventricular wall, changes in cardiac
actomyosin ATP-ase activity and increase of anti-myosin autoantibodies level.